REDCARE PHARMACY NV (RDC.DE) Stock Price, Quote, News and Overview

What is the stock price of REDCARE PHARMACY NV today?

The current stock price of RDC.DE is 128.5 EUR. The price increased by 0.08% in the last trading session.

What is the ticker symbol for REDCARE PHARMACY NV stock?

The exchange symbol of REDCARE PHARMACY NV is RDC and it is listed on the Deutsche Boerse Ag exchange.

On which exchange is RDC.DE stock listed?

RDC.DE stock is listed on the Deutsche Boerse Ag exchange.

What is the price forecast or stock price prediction for REDCARE PHARMACY NV stock?

19 analysts have analysed RDC.DE and the average price target is 169.32 EUR. This implies a price increase of 31.77% is expected in the next year compared to the current price of 128.5. Check the REDCARE PHARMACY NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is REDCARE PHARMACY NV worth?

REDCARE PHARMACY NV (RDC.DE) has a market capitalization of 2.64B EUR. This makes RDC.DE a Mid Cap stock.

How many employees does REDCARE PHARMACY NV have?

REDCARE PHARMACY NV (RDC.DE) currently has 1900 employees.

What are the support and resistance levels for REDCARE PHARMACY NV (RDC.DE) stock?

REDCARE PHARMACY NV (RDC.DE) has a support level at 127.71 and a resistance level at 134.91. Check the full technical report for a detailed analysis of RDC.DE support and resistance levels.

Is REDCARE PHARMACY NV (RDC.DE) expected to grow?

The Revenue of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 24.49% in the next year. Check the estimates tab for more information on the RDC.DE EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy REDCARE PHARMACY NV (RDC.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of RDC.DE, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of RDC.DE, evaluating the profitability, health, valuation and growth aspects
• REDCARE PHARMACY NV (RDC.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• REDCARE PHARMACY NV (RDC.DE) Sales and EPS estimates to see what analysts future expectations are.
• REDCARE PHARMACY NV (RDC.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• REDCARE PHARMACY NV (RDC.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
• REDCARE PHARMACY NV (RDC.DE) Stock Chart to make your own analysis
• REDCARE PHARMACY NV (RDC.DE) Latest news and press-releases to stay up to date.

Does REDCARE PHARMACY NV (RDC.DE) stock pay dividends?

RDC.DE does not pay a dividend.

When does REDCARE PHARMACY NV (RDC.DE) report earnings?

REDCARE PHARMACY NV (RDC.DE) will report earnings on 2025-05-06.

What is the Price/Earnings (PE) ratio of REDCARE PHARMACY NV (RDC.DE)?

REDCARE PHARMACY NV (RDC.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.33).

ChartMill assigns a fundamental rating of 4 / 10 to RDC.DE. RDC.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.

Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -2.33. The EPS decreased by -200.05% compared to the year before.

ChartMill assigns a Buy % Consensus number of 78% to RDC.DE. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of 42.87% and a revenue growth 24.49% for RDC.DE